European Research Biology Center (ERBC) articulates the technical, scientific and regulatory expertise, know-how and track record required for non-clinical studies of any type of drug candidate, from preclinical proof-of-concept to market.
Same applies to any Chemical Compound for its homologation.
Based on our extensive experience and thanks to our large historical database we are able to provide strategic considerations, and the best adapted proposals.
This enables us to enter into scientific dialogue, defining optimal research programs that cater for the individual needs of our clients.
Numerous pathophysiological models have been established and specific techniques have been developed and validated at ERBC in order to meet customized investigative requirements.
Expertise in pharmacology, cardiology, electrophysiology and pathophysiology